Olopatadine Hydrochloride is an antiallergic/antihistaminic agent and when administered topically, it can be absorbed systemically. If serious reactions or hypersensitivity occur, discontinue the use of this treatment.
Benzalkonium chloride which is generally used as a preservative material in ophthalmic products has been reported to cause punctate keratopathy and/or toxic ulcerative keratopathy. Close monitoring is required frequently and regularly in dry eye patients or in conditions where the cornea is compromised due to Olopatadine Hydrochloride containing benzalkonium chloride, or in conditions where the cornea is compromised.
Contact lenses: It is suitable to wait 10-15 minutes after Olopatadine Hydrochloride instillation before re-inserting contact lenses.
Effects on the ability to drive and use machines: As with other eye drops, temporary blurred vision or other visual disturbances may affect the ability to drive or use machines. If blurred vision occurs after instillation, the patient should wait until the vision clears before driving or using machinery.
Other Services
Country
Account